ENTEROSYS participates in the European project ThinkGut

Thinkgut

PERSONALIZED PREDICTION OF COGNITIVE FUNCTIONS BY THE HUMAN MICROBIOTA

CREATE TOOLS TO TREAT NEUROCOGNITIVE DISORDERS

The deterioration of cognitive functions is one of the main threats to the world population, due to the increase in life expectancy. The intestinal microbiota is considered as a major player in many diseases such as obesity and type 2 diabetes.

Studies conducted with different animal models have identified characteristic profiles of the microbiota associated with different cognitive functions.

The main objective of the ThinkGut project is to better understand the microbiota-cognition relationship, through the use and development of exploratory tools and human databases. These will have the potential to generate personalized diagnostic-therapeutic tools focused on the prevention, diagnosis and treatment of neurocognitive disorders associated with aging and obesity.

3 COMPLEMENTARY TEAMS

To carry out this research project, a cross-border consortium has been formed in the field of microbiota, gut-brain axis and cognition.

This project is led by the Institut d’Investigació Biomèdica de Girona (IDIBGI) in association with the Institut National de la Santé et de la Recherche Médicale (INSERM) and Enterosys.

ENTEROSYS, EXPERT IN R&D

Enterosys is in charge of cellular and molecular analysis of the neurons of the enteric nervous system and the study of the gut-brain axis in animal models.

A MODEL OF HUMANIZED MICE

For the ThinkGut project, a model of humanized mice was designed by colonizing mice with the flora of obese patients, with or without cognitive disorders.

These humanized mice are intended for the research of new drugs and/or antibiotics, focused on the prevention, diagnosis and treatment of neurocognitive disorders associated with aging and obesity.

For more information : Thinkgut.eu

This project has been co-financed up to 65% by the Fonds Européen de Développement Régional (FEDER) through the Interreg V-A Spain-France-Andorra Program (POCTEFA 2014-2020).

Research

Categorie

Archives

Enterosys welcomes its new assistant engineer

Manon Carratala Lasserre joined the Enterosys team in November 2022 and is in charge of service delivery. She obtained a Master’s degree in Immunology and infectious diseases at the Paul Sabatier University in Toulouse. During her internships, she first worked on...

Enterosys participates in Biofit 2022 in Strasbourg

With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing...

Enterosys will attend NutrEvent 2022 in Nantes

NutrEvent is the event dedicated to innovation in Food, Feed, Nutrition and Health. This year, NutrEvent is back for its 8th edition in a hybrid format. This hybrid event will be held both in-person and online. Enterosys will be present with a validated, complete and...

Enterosys welcomes its new business developer

This month, Pauline Caseilles joined the Enterosys team as a Scientific Business Developer. Her mission: to publicize Enterosys' service offerings. Pauline obtained a Master’s degree in Health Biology and a Specialized Mastere in Marketing and Sales also in the field...

Antioxidant and anti-inflammatory properties of maternal milk

The high hydrostatic pressure processing of donor milk may better protect preterm infants from gut and liver pathologies compared to Holder pasteurization, which is currently used in most human milk banks Preterm infants are highly susceptible to oxidative stress due...